Pretreatment neutrophil-to-lymphocyte ratio and its dynamic change during neoadjuvant chemotherapy as poor prognostic factors in advanced ovarian cancer-Reference-Cited by-同舟云学术

Pretreatment neutrophil-to-lymphocyte ratio and its dynamic change during neoadjuvant chemotherapy as poor prognostic factors in advanced ovarian cancer

Published:2018 Issue:2 Volume:61 Page:227
ISSN:2287-8572
Container-title:Obstetrics & Gynecology Science
language:en
Short-container-title:Obstet Gynecol Sci

Author:

Kim Yun-Ji¹,Lee Inha¹,Chung Young Shin¹,Nam EunJi¹,Kim Sunghoon¹,Kim Sang-Wun¹,Kim Young Tae¹,Lee Jung-Yun¹^ORCID

Affiliation:

1. Department of Obstetrics and Gynecology, Institute of Women's Life Medical Science, Yonsei University College of Medicine, Seoul, Korea.

Funder

National Research Foundation of Korea

Publisher

Korean Society of Obstetrics and Gynecology

Subject

Obstetrics and Gynaecology

Link

https://synapse.koreamed.org/pdf/10.5468/ogs.2018.61.2.227

Reference30 articles.

1. Global cancer statistics, 2012

2. Trends in gynecologic cancer mortality in East Asian regions

3. Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010

4. National Comprehensive Cancer Network (US). Clinical practice guidelines in oncology [Internet]. Washington (PA). National Comprehensive Cancer Network. 2016. cited 2016 Dec 13. Available from: https://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf

5. Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of neutrophil-to-lymphocyte ratio and fibrinogen levels in ovarian cancer;Medical Journal of Indonesia;2023-10-02

2. Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery;International Journal of Molecular Sciences;2023-07-13

3. Trends in Systemic Inflammatory Reaction (SIR) during Paclitaxel and Carboplatin Chemotherapy in Women Suffering from Epithelial Ovarian Cancer;Cancers;2023-07-13

4. Systemic inflammation factors as survival prognosis markers in ovarian neoplasm and the relationship with cancer-associated inflammatory mediators—a review;International Journal of Immunopathology and Pharmacology;2023-05-28

5. Independent predictive value of blood inflammatory composite markers in ovarian cancer: recent clinical evidence and perspective focusing on NLR and PLR;Journal of Ovarian Research;2023-02-09